We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Artificial Implant Prosthesis Could Replace Spinal Fusion

By HospiMedica International staff writers
Posted on 13 Jan 2014
A novel artificial spinal joint restores function to the posterior spinal column in people suffering from spinal stenosis.

The Total Posterior Solution (TOPS) system is a titanium-sandwiched implant that effectively replaces anatomical structures removed from the vertebrae during the spinal decompression treatment to alleviate pain, such as the lamina or the facet joint. More...
Thus, the boot and internal components of the implant take the place of the supraspinous ligament, interspinous ligament, and ligamentum flavum in their ability to help control flexion. The internal metal stoppers replace the natural bony elements that served as stoppers during axial rotation.

The implant thus allows axial rotation, lateral bending, extension, and flexion, facilitating bending, twisting, and straightening movements at the affected segment of the spine, while blocking excessive posterior and anterior sagittal translation. Once a controlled range of movement is reestablished, patients regain their ability to bend, flex, walk, and enjoy the normal activities of life, while at the same time experiencing immediate and sustained pain relief. The system also protects adjacent levels of the spine from similar degeneration, a common unwanted side effect of fusion surgery.

As with most spinal fusion devices, the TOPS System is anchored to the spine with four standard polyaxial pedicle screws, and is implanted via a traditional posterior surgical approach. The system is intended for adult patients following decompression surgery to alleviate pain stemming from spinal stenosis and/or degenerative spondylolisthesis affecting the L3-L5 lumbar region of the spine, when nonsurgical treatments have failed to provide relief. The TOPS System is a product of Premia Spine (Netanya, Israel), and can be used in conjunction with Premia Spine's Versalink Fixation System to address multilevel diseases of the spine.

“We’ve developed an implant that recreates all functions of the posterior spinal column, where there are important joints, ligaments, and bony structures that provide control over twisting, bending, and flexing,” said Ron Sacher, CEO of Premia Spine. “With the TOPS System, instead of immobilizing we replace the diseased segment with an artificial joint.”

Related Links:

Premia Spine



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Patient Monitor
IntelliVue MP5SC
New
Antimicrobial Mat
MULTIMAT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.